DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Muir APF editor LB 2;
All-oral fixed dose combination therapy with daclatasvir / asunaprevir / BMS 791 325 +/- for patients with chronic HCV genotype 1 infection and compensated cirrhosis:UNITY-2 Phase 3 SVR12 resutls.
AASLD 2014; 2014
Boston:
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.